Clinical Evaluation of a Cochlear Implant System

NCT03467399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2018-03-16

No results posted yet for this study

Summary

The primary objective of this study is to assess the usability of a Cochlear implant system.

Conditions

  • Sensorineural Hearing Loss

Interventions

DEVICE

Nucleus 7 Cochlear Implant System

A new cochlear implant sound processor system.

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Mary Beth Brinson · Cochlear Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2017-09-07
Completion
2017-09-07

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03467399 on ClinicalTrials.gov